Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, California, USA.
Collaborative Mass Spectrometry Innovation Center, UC San Diego, La Jolla, California, USA.
Pharmacotherapy. 2023 May;43(5):442-451. doi: 10.1002/phar.2732. Epub 2022 Oct 18.
Antibiotics are an essential tool for perinatal care. While antibiotics can play a life-saving role for both parents and infants, they also cause collateral damage to the beneficial bacteria that make up the host gut microbiota. This is especially true for infants, whose developing gut microbiota is uniquely sensitive to antibiotic perturbation. Emerging evidence suggests that disruption of these bacterial populations during this crucial developmental window can have long-term effects on infant health and development. Although most current studies have focused on microbial disruptions caused by direct antibiotic administration to infants or prenatal exposure to antibiotics administered to the mother, little is known about whether antibiotics in human milk may pose similar risks to the infant. This review surveys current data on antibiotic transfer during lactation and highlights new methodologies to assess drug transfer in human milk. Finally, we provide recommendations for future work to ensure antibiotic use in lactating parents is safe and effective for both parents and infants.
抗生素是围产期护理的重要工具。虽然抗生素对父母和婴儿都能起到挽救生命的作用,但它们也会对构成宿主肠道微生物群的有益细菌造成附带损害。对于婴儿来说尤其如此,因为他们正在发育的肠道微生物群对抗生素的干扰特别敏感。新出现的证据表明,在这个关键的发育窗口期破坏这些细菌群体会对婴儿的健康和发育产生长期影响。尽管大多数当前的研究都集中在直接向婴儿给予抗生素或母亲在产前接触给予的抗生素引起的微生物破坏上,但对于人乳中的抗生素是否可能对婴儿构成类似的风险知之甚少。本综述调查了哺乳期抗生素转移的当前数据,并强调了评估人乳中药物转移的新方法。最后,我们为未来的工作提供了建议,以确保哺乳期父母使用抗生素对父母和婴儿都是安全有效的。